Location: Virtual via Zoom (After registration Zoom link is availble under "Course Materials" section and will also be emailed to all registered participants prior to the activity)
Target Audience: Pharmacists
Fee: Free
Speakers and Topics:
* Please scroll down and click the plus sign (+) next to the session title to view specific learning objectives for pharmacists
Recognizing Key Symptoms and At-Risk Patients Monday, March 21 8:00-9:00 PM (EST)
Andrew Mardis, PharmD, BCCP, BCPS
Affiliate Assistant Professor, UofSC COP; Clinical Pharmacy Specialist; Mechanical Circulatory Support & Advanced Heart Failure, Prisma Health
|
After participating in the proposed educational activity, pharmacists in all healthcare settings will be able to:
- Recognize the distinct clinical manifestations associated with ATTR-CM in order to assist with the detection of this currently underdiagnosed disease in everyday practice
- Identify certain populations that are at greater risk of ATTR-CM so as to facilitate early screening and diagnosis before progression of the disease
Optimizing and Increasing Access to Treatment Wednesday, March 23 8:00-9:00PM (EST)
Hayley T. Davis, PharmD
PGY2 Ambulatory Care Pharmacy Resident, Medical University of South Carolina
|
|
Morgan Lange, PharmD
Clinical Pharmacist, Medical University of South Carolina Specialty Pharmacy
|
After participating in the proposed educational activity, pharmacists in all healthcare settings will be able to:
- Compare and contrast available pharmacologic and non-pharmacologic treatment options for ATTR-CM
- Recommend and increase access to the most appropriate pharmacologic treatment options for patients suffering from ATTR-CM
Date: Mar 21, 2022 08:00 PM - Mar 23, 2022 09:00 PM
Fee
$0.00
CE Hours
2.00
CE Units
0.200
Registration closes on Mar 23, 2022 07:00 PM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
Accreditation(s)
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
Participants must sign in upon arrival and have attendance verified.
To claim credit for this activity, participants must complete the online program evaluations and must update their accounts to properly reflect their month/day of birth and correct NABP e-Profile ID. To register with NABP or look up your NABP e-Profile ID, please click on the CPE Monitor logo below to be directed to their site.
Credit that is claimed greater than 60 days from the date of the program will be automatically rejected by the CPE Monitor. Claiming credit within 30 days of the live program will ensure that any issues with transmission to the CPE Monitor can be rectified in advance of the 60-day deadline. If you would like a paper statement of credit, you may print an individual statement or a transcript from your NABP e-Profile.
Support/Credits
This presentation was made possible from an unrestricted grant from Pfizer.
Registration closes on Mar 23, 2022
at 07:00 PM
Registration closes on Mar 23, 2022
at 07:00 PM
Registration Closed
Registration Closed
After participating in the proposed educational activity, pharmacists in all healthcare settings will be able to:
- Recognize the distinct clinical manifestations associated with ATTR-CM in order to assist with the detection of this currently underdiagnosed disease in everyday practice
- Identify certain populations that are at greater risk of ATTR-CM so as to facilitate early screening and diagnosis before progression of the disease
Speaker(s)/Author(s)
B. Andrew Mardis, PharmD, BCPS
|
Activity Number
0062-0000-22-080-L01-P
Date:
03/21/22
Time:
08:00 PM - 09:00 PM
CE Hours
1.00
Registration Closed
Registration closes on Mar 23, 2022
at 07:00 PM
Registration closes on Mar 23, 2022
at 07:00 PM
Registration Closed
Registration Closed
After participating in the proposed educational activity, pharmacists in all healthcare settings will be able to:
- Compare and contrast available pharmacologic and non-pharmacologic treatment options for ATTR-CM
- Recommend and increase access to the most appropriate pharmacologic treatment options for patients suffering from ATTR-CM
Speaker(s)/Author(s)
Hayley Davis, PharmD
|
|
Morgan Lange, PharmD
|
Activity Number
0062-0000-22-081-L01-P
Date:
03/23/22
Time:
08:00 PM - 09:00 PM
CE Hours
1.00
Registration Closed